SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Galectin Therapeutics Inc. (GALT) News

Track canonical SquawkNews coverage tagged to GALT, Galectin Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol GALT Asset equity Sector Markets 90 days 5 Last 3.89 Updated Sep 10, 2026, 12:04 PM UTC Open live news feed
L Galectin Therapeutics to present at H.C. Wainwright 28th annual conference EQUITY | Sep 10, 2026, 12:04 PM UTC L GALT - Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference GALT - Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference EQUITY | Sep 10, 2026, 12:00 PM UTC L Galectin Therapeutics reports June 30, 2026 financial results Galectin Therapeutics (GALT) reports financial results for the period ended June 30, 2026 and provides a business update. EARNINGS | Aug 14, 2026, 12:00 PM UTC H Galectin Therapeutics Converts $105.8M Debt To Equity Galectin Therapeutics converts debt to equity EQUITY | Aug 04, 2026, 12:00 PM UTC L Top 3 Health Care Stocks That May Keep You Up At Night In June As of June 30, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a REGULATION | Jun 30, 2026, 12:55 PM UTC M 12 Health Care Stocks Move Twelve health care stocks are moving in Tuesday's intraday session, with Aditxt and Atlantic International leading the gainers and Trinity Biotech and Tenon Medical leading the losers EQUITY | Jun 23, 2026, 05:09 PM UTC H GALT: Meets FDA Galectin Therapeutics announces positive Type C meeting with the FDA for Belapectin in patients with MASH cirrhosis and portal hypertension EQUITY | Jun 23, 2026, 12:01 PM UTC